Repligen (RGEN) - Stock price history

Stock price history of Repligen from 1986 to 2026

Annual Stock Price Performance

Year	Performance
2026	3.73%
2025	14.55%
2024	-19.72%
2023	10.99%
2022	-34.37%
2021	38.91%
2020	104.34%
2019	78.95%
2018	42.31%
2017	16.47%
2016	9.68%
2015	40.75%
2014	56.77%
2013	105.73%
2012	79.43%
2011	-23.23%
2010	16.09%
2009	4.85%
2008	-43.16%
2007	133.93%
2006	-27.95%
2005	37.93%
2004	-30.77%
2003	47.14%
2002	13.01%
2001	-31.79%
2000	10.20%
1999	127.27%
1998	24.24%
1997	-35.90%
1996	11.76%
1995	-40.00%
1994	-75.00%
1993	-27.63%
1992	-44.12%
1991	29.17%
1990	25.00%
1989	37.93%
1988	-17.65%
1987	-11.11%
1986	-22.22%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Novavax NVAX	8,47 €	20.73%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	48,56 €	0.82%	🇺🇸 USA
Neurocrine Biosciences NBIX	115,82 €	0.65%	🇺🇸 USA
General Electric GE	272,41 €	1.97%	🇺🇸 USA
Thermo Fisher Scientific TMO	544,23 €	2.79%	🇺🇸 USA
Bristol-Myers Squibb BMY	46,61 €	0.52%	🇺🇸 USA
Pfizer PFE	22,14 €	1.45%	🇺🇸 USA
Bio-Techne TECH	61,05 €	2.60%	🇺🇸 USA
Sangamo Therapeutics SGMO	0,33 €	3.91%	🇺🇸 USA
Charles River Laboratories CRL	193,96 €	3.93%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Repligen (RGEN)